Compassionate Freedom of Choice Act of 2015
Latest action · Feb 6, 2015 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 5, 2015
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Compassionate Freedom of Choice Act of 2015
This bill amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act prevents or restricts, and the Food and Drug Administration (FDA) must not prevent or restrict, the manufacture, importation, distribution, or sale of investigational drugs or devices for terminally ill patients.
The FDA is prohibited from requiring the disclosure, collection, or reporting of certain information concerning such drugs or devices, except that the sponsor of a clinical trial may voluntarily disclose, collect, or report such information to the FDA.
Except in cases of gross negligence or willful misconduct, any person who manufactures, imports, distributes, prescribes, or administers an investigational drug or device is not liable under state or federal law for loss, damage, or injury from: (1) the development, testing, production, acquisition, or use of such drugs or devices; or (2) their safety or effectiveness.
Cosponsors 4
Members who signed on, in the order they did. Signatures ran from Feb 5, 2015 to Feb 1, 2016; 1 is an original cosponsor, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-NY | Richard L. Hanna | Original | Feb 5, 2015 |
| R-VA | Dave Brat | Jun 24, 2015 | |
| D-CO | Jared Polis | Jan 13, 2016 | |
| R-AL | Mo Brooks | Feb 1, 2016 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 5, 2015 |
| Health Subcommittee | Referred Feb 6, 2015 |
Actions 3
Everything that happened, newest first.
- Feb 6, 2015Referred to the Subcommittee on Health.
- Feb 5, 2015Introduced in House
- Feb 5, 2015Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 161, no. 20, February 5, 2015, page H857.
Printed hearings 1
Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.
| Number | Hearing | Committee | Held |
|---|---|---|---|
| Serial No. 114-13 | EXAMINING THE FISCAL YEAR 2016 HHS BUDGET111 pages | Energy and Commerce Committee | Feb 26, 2015 |
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R44134 | Access to Unapproved Drugs: FDA Policies on Compassionate Use and Emergency Use Authorization Archived | Report | Aug 4, 2015 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| HR 1020 | Compassionate Freedom of Choice Act of 2017 | Reintroduced Bill | Feb 17, 2017 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To allow the manufacture, importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document, and for other purposes.
- Short Titles as Introduced
- Compassionate Freedom of Choice Act of 2015
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Feb 5, 2015Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.
